"Global Genomic Surveillance Strengthened by Collaborative Lab Efforts"

Laboratories in Britain and South Africa, known for tracking COVID-19 variants, have joined forces to maintain global genomic surveillance beyond the pandemic, expressing concerns that governments and funders may reduce support for such efforts. The collaboration aims to continue monitoring infectious diseases like malaria and cholera, leveraging the infrastructure established during the pandemic. The labs will share resources and expertise to support disease surveillance worldwide, emphasizing the potential for genomic surveillance to benefit public health beyond COVID-19.